background: Soluble human leucocyte antigen-G (sHLA-G) is secreted by extravillous trophoblast (EVT) and has roles in regulating immune cells within the decidua. HLA-G expression on EVT increases as they approach uterine spiral arteries and we have suggested that sHLA-G may be important in the remodelling of these vessels. The autocrine role of sHLA-G in regulating trophoblast function at this critical phase has not been studied. We aimed to investigate the effects of sHLA-G on trophoblast motility, invasion and survival.
Introduction
Cytotrophoblasts play a central role in the development and maintenance of a successful pregnancy. In humans, trophoblasts differentiate from cytotrophoblast stem cells along two pathways. Villous trophoblasts fuse to form a syncytium and are bathed in maternal blood, whereas extravillous trophoblasts (EVTs) invade the decidua. The EVTs migrate from the anchoring villi to form two subpopulations. The interstitial EVT invade the uterine wall, whereas the endovascular EVTs migrate along the lumen of the spiral artery retrograde to blood flow as far as the myometrial segment (Pijnenborg et al., 2006) . Through mechanisms that may involve trophoblast-mediated apoptosis of endothelial and smooth muscle cells of the vessel wall (Ashton et al., 2005; Harris et al., 2006) , EVTs remodel the maternal uterine arteries transforming them from small diameter, high-resistance into large diameter, low-resistance vessels (Robertson et al., 1973) . This is accompanied by loss of internal elastic lamina and musculo-elastic media and the deposition of an amorphous fibrinoid material (Brosens et al., 1967; Pijnenborg et al., 1983) . Insufficient EVT invasion and artery remodelling are associated with the development of preeclampsia, intrauterine growth restriction and placental abruption; however, the exact aetiology of these disorders is not fully understood (Brosens et al., 1970; Meekins et al., 1994; Anin et al., 2004) .
The non-classical major histocompatibility complex type one molecule, HLA-G, exhibits restricted expression, limited polymorphism and is alternatively spliced generating up to seven isoforms (Ellis et al., 1990; Kovats et al., 1990; Yelavarthi et al., 1991; Ishitani and Geraghty, 1992; Fujii et al., 1994; Moreau et al., 1995) . Cells that express membrane bound HLA-G are resistant to natural killer cell induced cytotoxicity suggesting that it is involved in immune tolerance (Chumbley et al., 1994; Deniz et al., 1994; Rouas-Freiss et al., 1997; Marchal-Bras-Goncalves et al., 2001) . HLA-G1, -G2, -G3 and -G4 all contain cytoplasmic and transmembrane domains; however, only HLA-G1 can be expressed at the membrane, whereas the others are sequestered in the endoplasmic reticulum (Geraghty et al., 1987; Mallet et al., 2000; Le Bouteiller et al., 2003) . The soluble forms of HLA-G1 and -G2 (HLA-G5 and -G6, respectively) retain intron 4 that contains a stop codon thereby preventing the translation of the transmembrane domain (Fujii et al., 1994; Bainbridge et al., 2001) . A seventh HLA-G isoform has been described (HLA-G7) which has been shown to be generated by the presence of a stop codon in intron 2; however, a HLA-G7 secreted product has not yet been described (Paul et al., 2000; Le Bouteiller et al., 2003) .
HLA-G binds to and activates a number of cell surface receptors expressed by NK and endothelial cells including killer immunoglobulinlike receptor protein, KIR2DL4, Ig-like transcript-2 (ILT-2) and the GPI-anchored receptor, CD160 (Rajagopalan and Long, 1999; Shiroishi et al., 2003; LeMaoult et al., 2005; Fons et al., 2006; Apps et al., 2007) . Binding of HLA-G to uterine natural killer cells leads to modulation of NK cell cytokine secretion (Rajagopalan et al., 2006) .
The expression of HLA-G by both endovascular and interstitial EVT increases as they migrate towards the vasculature (McMaster et al., 1995) . In vitro studies indicate that soluble isoforms of HLA-G (sHLA-G1 or HLA-G5) induce apoptosis in activated endothelial cells, natural killer (NK) and alloreactive cytotoxic T cells (Zavazava and Kronke, 1996; Fons et al., 2006; Lindaman et al., 2006) . HLA-G5 has also been found to inhibit growth factor-induced capillary formation in vitro, suggesting a possible role in vascular remodelling (Fons et al., 2006; Le Bouteiller et al., 2007) . Indeed, defective HLA-G expression has been associated with the pregnancy complication pre-eclampsia (Lim et al., 1997; Yie et al., 2004) . We aimed to investigate whether HLA-G has an autocrine role in regulating trophoblast invasion, motility and survival. Here, we demonstrate that soluble HLA-G suppresses growth factor-stimulated motility and invasion of the human trophoblast cell line, SGHPL-4. These data provide further evidence that HLA-G may be important in the events occurring in the utero-placental environment in early pregnancy by not only regulating interactions with maternal immune cells and endothelial cells but also in the regulation of trophoblast migration.
Materials and Methods

Culture of SGHPL-4 cells
The SGHPL-4 cell line, derived from primary human first trimester EVTs, is well characterized and shares many characteristics with primary EVT, including expression of HLA-G, cytokeratin-7, CD9 and hPL. SGHPL-4 cells were cultured in Hams F10 media (Sigma-Aldrich, Dorset, UK) supplemented with 10% (v/v) fetal calf serum (FCS; Sigma-Aldrich), 2 mM L-glutamine (Sigma-Aldrich), 100 U/ml penicillin and 100 mg/ml streptomycin (Sigma-Aldrich).
Generation of SGHPL-4 cells over-expressing soluble HLA-G (SGHPL-4sG1)
The cDNA encoding sHLA-G was digested from the pcDNA3/sHLA-G construct and subcloned into the pcDNA-3/hygro backbone (Invitrogen, Paisley, UK; Fournel et al., 1999) . This construct was transfected into the wild-type trophoblast cell line SGHPL-4 using FuGene6 reagent (Roche, Sussex, UK) and stable transfectants selected in Hams F10 containing 10% (v/v) FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml and 150 mg/ml hygromycin B (Roche). The concentration of hygromycin B had been previously determined as the concentration that caused death of non-transfected SGHPL-4 cells within 5 days. The SGHPL-4sG1 cells were maintained in complete Hams F10 media containing 50 mg/ml hygromycin B and cultured at 378C in 5% CO 2 in air.
PCR amplification
Total RNA was extracted from SGHPL-4 and SGHPL-4sG1 cells using Trizol (Invitrogen) and cDNA synthesized using the first-strand cDNA synthesis kit (GE Healthcare, Buckinghamshire, UK). PCR amplification of HLA-G and b 2 -microglobulin message was performed as described previously (Langat et al., 2006) .
HLA-G ELISA
Soluble HLA-G levels were determined using the soluble HLA-G-specific ELISA according to the manufacturer's instructions (Biovendor, Heidelberg, Germany). Briefly, 20 ml conditioned media was removed from a confluent T175 flask and centrifuged at 300g to pellet any cell debris. The clarified supernatant was then subjected to specific ELISA.
Assessment of cell number
Cell numbers of the SGHPL-4 and the SGHPL-4sG1 cells were determined using a haemocytometer. Cells were seeded onto 10 cm culture dishes at a density of 5 Â 10 5 per plate and cell counts taken at 24, 48 and 72 h.
Motility assay
SGHPL-4 and SGHPL-4sG1 cells (3 Â 10 4 /well, 12-well plate) were allowed to adhere overnight in Hams F10 containing 10% (v/v) FCS and the medium replaced with Hams F10 containing 0.5% (v/v) FCS for a further 24 h. At the end of this period, cell motility was determined in response to hepatocyte growth factor (HGF, 10 ng/ml; Peprotech, NJ, USA) and epidermal growth factor (EGF, 10 ng/ml; Peprotech) at 378C in 5% CO 2 in air. Images were captured every 15 min over 6 h using a CCD camera (Hamamatsu model C4742-95) connected to an Olympus IX 70 phase contrast microscope as described previously (Cartwright et al., 1999) . At least 20 cells per field of view were chosen at random and the distance moved was quantified using Image Pro-Plus software (Media Cybernetics, MD, USA).
Apoptosis assay
SGHPL-4 and SGHPL-4sG1 cells were seeded onto 6-well culture plates and cultured for 24 h. The medium was replaced with Hams F10 containing 0.5% (v/v) FCS, 30 ng/ml tumour necrosis factor (TNF) and 800 ng/ ml actinomycin D (ActD). Apoptosis was monitored by time -lapse microscopy (TLM) using an Olympus IX70 inverted phase contrast microscope with a motorized stage and cooled CCD camera (Hamamatsu model C4742-95) enclosed in a humidified chamber at 378C with 5% CO 2 in air as described previously Whitley et al., 2007) . Images were captured at 15 min intervals over 24 h and timelapse sequences were analysed using ImagePro Plus (Media Cybernetics). Forty cells were scored in each field of view and the time at which apoptotic morphology was first observed was recorded (characterized by membrane blebbing, cytoplasmic shrinkage, nuclear condensation, a phase bright appearance and the formation of blisters).
Invasion assay
Determination of cell invasion was carried out as previously described with minor modifications (Nehls and Drenckhahn, 1995) . Gelatin-coated cytodex-3 microcarrier beads (Sigma-Aldrich) were prepared according to the manufacturer's recommendations. Cells were removed from the culture vessel using trypsin/EDTA, washed once with PBS and resuspended at a density of 5 Â 10 5 cells/ml with 1500 beads/ml. Following incubation at 378C for 1 h to allow cells to adhere to the beads, cell-coated beads were washed three times with PBS. Fibrin gels were prepared by dissolving bovine fibrinogen (.95% of protein clottable, Sigma) in PBS at a concentration of 2.5 mg/ml and adding 200 U/ml aprotinin (Bayer, Leverkusen, Germany). Cell-coated beads were added at a density of 150 beads/ml and clotting was induced by the addition of thrombin (0.625 U/ml, Sigma-Aldrich). Fibrin gels were allowed to form on 6-well plates with 1.5 ml/well. After clotting, the gels were equilibrated with culture medium supplemented with 0.5% (v/v) FCS for 1 h. The medium was replaced with fresh medium (1:1 volume with the gel) and the cells incubated at 378C in a humidified atmosphere of 5% CO 2 . After 24 h, the medium was replaced with medium (0.5% FCS) containing the stimulus as indicated. After 3 days, at least 10 beads from each plate were chosen at random and images were captured using an Olympus IX 70 phase contrast microscope. The number and length of the processes formed were determined using Image Pro-Plus software (Media Cybernetics). and the membrane blocked in 4% (w/v) non-fat dry milk. The membrane was interrogated using anti-HLA-G (MEM-G/1; Abcam, Cambridge, UK) or anti-GAPDH (Clone 6C5; Millipore, Hertfordshire, UK). Horseradish peroxidase-conjugated secondary antibodies were from Sigma-Aldrich. Proteins were visualized using enhanced chemiluminescence (GE Healthcare) and exposed to Hyperfilm (GE Healthcare).
Western blot analysis
Statistical analysis
All data are expressed as mean + standard error of the mean (SEM) of n observations, where n represents the number of replicate experiments. Statistical significance was determined by repeated measures one-way Figure 1 Characterization of SGHPL-4sG1 cells. (A) Total RNA was extracted from SGHPL-4 and SGHPL-4sG1 cells using Trizol and first-strand cDNA synthesis performed. HLA-G and b 2 -microglobulin (b2M) was PCR amplified as described previously (Langat et al., 2006) . A strong HLA-G band was present in the SGHPL-4sG1 cells, which was not present in the wild-type cells. Actin was used to demonstrate equal loading in all lanes. (B) To confirm the over-expressed message was translated to protein immunoblotting of cell lysates was performed using the MEM-G/1 monoclonal antibody. Immunoblotting showed a significant increase in HLA-G (37 kDa) protein levels compared with the wild-type control. Actin was used to demonstrate equal loading in all lanes. (C) An HLA-G-specific ELISA was used to test 3-day culture supernatants to ensure that the protein was secreted from the stable cell line. The SGHPL-4sG1 cells demonstrated 25-fold increase in soluble HLA-G.
Soluble HLA-G regulates motility and invasion of sGHPL-4 cells ANOVA with Tukey's post test using Prism 5 statistics software package (Graphpad, CA, USA) unless otherwise stated.
Results
Characterization of EVT cells over-expressing SHLA-G (SGHPL-4sG1)
SGHPL-4 cells were transfected with a pcDNA3 construct containing the soluble HLA-G cDNA. Stable transfectants were cultured under 150 mg/ml hygromycin B selection for 14 days then maintained in 50 mg/ml hygromycin B and expression of the soluble isoform in this heterogeneous population was confirmed by RT -PCR and western blotting (Fig. 1A and B) . Using an HLA-G-specific ELISA, culture supernatants were analysed to confirm the protein was being secreted into the culture media. As shown in Fig. 1C , 3-day culture supernatants from the stable cell lines were found to contain 25-fold more HLA-G than the wild-type parent line.
Soluble HLA-G inhibits HGF-induced trophoblast motility
We postulated that sHLA-G may elicit an effect on EVT in an autocrine manner. The EVT cell line, SGHPL-4, and the SGHPL-4sG1 were seeded onto 6-well culture dishes at a density of 3 Â 10 5 per well and cultured in the presence or absence of HGF (10 ng/ml) or EGF (10 ng/ml). Over-expression of sHLA-G had no significant effect on basal motility but did significantly inhibit HGF-stimulated motility (P , 0.05, n ¼ 6; Fig. 2) . Soluble HLA-G did not significantly reduce EGF-stimulated motility (n ¼ 6, Fig. 2 ). The production of active sHLA-G by either wild-type or SGHPL-4sG1 cells was unaffected by stimulation with either HGF or EGF (data not shown).
Soluble HLA-G does not induce trophoblast apoptotic cell death or sensitize cells to apoptotic stimuli SGHPL-4 or SGHPL-4sG1 cells were seeded onto 6-well culture vessels and cultured in the presence of TNF-a and ActD. Cell death was assessed using phase contrast TLM with apoptotic cells appearing as rounded, phase bright cells with membrane blebbing. No difference in the level of apoptotic cell death was observed between the two cell types (Fig. 3) . Basal levels of apoptosis in the absence of TNF-a and ActD were 5% with no differences between SGHPL-4 and SGHPL-4sG1 (data not shown).
Soluble HLA-G inhibits trophoblast invasion
Since cell motility was reduced by HLA-G in HGF-stimulated trophoblasts, we wanted to determine whether HLA-G could reduce the invasive potential of the trophoblast. Both HGF and EGF increased the formation of invasive processes by SGHPL-4 and SGHPL-4sG1 cells cultured on microcarrier beads embedded in fibrin gels for 72 h. There was no significant difference in either the length or number of invasive processes between SGHPL-4 and the SGHPL-4sG1 cells under control conditions (no additional growth factors; Fig. 4A ). However, upon stimulation with either EGF or HGF, there was a significant reduction in both length ( Fig. 4A ; EGF, P , 0.01; HGF, P , 0.05) and number (EGF, P , 0.001; HGF, Figure 3 HLA-G does not induce trophoblast apoptosis. Apoptosis of SGHPL-4 and SGHPL-4sG1 cells was monitored using TLM. Cells were treated with TNF (30 ng/ml) and ActD (800 ng/ml) and cultured for 20 h. No significant difference in the sensitivity to apoptosis was observed between the two cell lines. Data are presented as mean + SEM of at least three individual experiments. Endpoint apoptosis experiments (20 h) were analysed using Student's t-test. and SGHPL-4sG1 cells were seeded onto culture plates then cultured in the presence of either HGF (10 ng/ml) or EGF (10 ng/ml) at 378C in 5% CO 2 in air. Images were captured over 6 h every 15 min. No difference in basal motility was observed, however, SGHPL-4sG1 cells showed decreased motility compared with the SGHPL-4 cells when treated with HGF. Data are presented as mean + SEM and analysed using a paired t-test.
P , 0.01, n ¼ 3) of invasive processes in SGHPL-4sG1 compared with the wild-type cells ( Fig. 4A and B) . A representative image is shown of SGHPL-4 invasive processes emanating from a cytodex microcarrier bead after 48-h unstimulated culture ( Fig. 4C; left panel) or following 48 h stimulation with EGF ( Fig. 4C; right panel) . The above data suggest that HLA-G may be responsible for modulating the invasive properties of the trophoblast. To exclude the possibility that these data were due to a reduction in the number of SGHPL-4sG1 or an increase in the number of SGHPL-4 under these conditions, an assessment of cell number was carried out. As shown in Fig. 4D , there was no difference observed between the two cell lines.
Discussion
EVTs invade the decidua and migrate towards the spiral arteries, where they interact and replace the vascular cells creating a high-flow, low-resistance vessel (Robertson et al., 1973) . In the most heavily modified vessels, the EVT can invade as far as the first third of the myometrium. Although a number of factors are known to stimulate trophoblast invasion, less is known of the negative regulators that may be involved (Pijnenborg et al., 1980) . It has been known for sometime that as the EVTs migrate further from the villous tip, the expression of HLA-G increases suggesting that HLA-G production is a critical component of cytotrophoblast differentiation and may play an important role in preventing excessive invasion (McMaster et al., 1995) . Here, we demonstrate for the first time that sHLA-G can inhibit growth factor-induced motility and invasion but does not affect cell growth or sensitivity to apoptotic stimuli.
The temporal and spatial regulation of trophoblast invasion is controlled by many factors. HGF and EGF are known to induce trophoblast motility and invasion and HGF is required for normal placental development in vivo (Bass et al., 1994; Cartwright et al., 1999) . The invasive nature of the trophoblast is partly due to its ability to Soluble HLA-G regulates motility and invasion of sGHPL-4 cells secrete matrix metalloproteinases (MMPs) with MMP9 shown to be up-regulated by EGF (Behrendtsen et al., 1992; Qiu et al., 2004) . It is interesting to speculate that HLA-G may be involved in the autocrine regulation of MMP production following stimulation, thereby modulating the invasive function of the trophoblast. This is supported by the current observation demonstrating that the number of invasive processes was significantly reduced in the SGHPL-4sG1 cells compared with SGHPL-4 cells following EGF treatment. Soluble HLA-G induces apoptosis in endothelial cells (Fons et al., 2006) . To examine whether increased expression of sHLA-G increased trophoblast apoptosis or increased the sensitivity of trophoblasts to exogenous apoptotic stimuli, we used TLM. This has significant advantages over more conventional biochemical approaches as it identifies the mode of death, distinguishing between apoptosis (phase bright cells) and necrosis (phase dark cells). Effects on cell attachment can also be monitored together with the kinetics of these processes. Using this approach, we were unable to see any significant difference in the rate of basal apoptosis indicating that the reduction in invasion seen in this study was not due to increased cell death. There was also no significant difference in the sensitivity of sHLA-G overexpressing cells to the exogenously added apoptotic stimuli, TNF-a and ActD.
The receptors involved and the intracellular mechanisms activated by sHLA-G in trophoblasts have yet to be determined. Soluble HLA-G is known to bind to and activate a number of receptors including but not exclusively the GPI-anchored receptor, CD160 and leucocyte immunoglobulin-like transcript ILT-4 and KIR2DL4. These receptors are differentially expressed on a number of cell types including endothelial cells (Fons et al., 2006) and uterine natural killer cells (Rajagopalan and Long, 1999) . The identity of the receptor and the signal transduction pathways involved in HLA-G regulation of trophoblast motility and invasion are currently under investigation.
Poor invasion can lead to complications such as miscarriage, preeclampsia and intrauterine growth restriction, whereas excessive invasion can result in placenta accreta or persistent trophoblastic disease (Anin et al., 2004) . The data presented here demonstrate that sHLA-G modulates EVT motility and invasion. However, in contrast to endothelial cells, EVTs remain resistant to sHLA-G-induced apoptosis. These data have shown for the first time that sHLA-G may be an important regulator of trophoblast invasion and spiral artery remodelling. It is possible that as the local concentration of HLA-G increases towards the spiral artery this modulates the invasive properties of the trophoblast thereby regulating its passage towards the vasculature. In this way, HLA-G is involved in the 'fine-tuning' of the invasive properties of the trophoblast, a process that warrants further investigation.
